These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11737595)

  • 21. Tubular lesions determine prognosis of IgA nephropathy.
    Daniel L; Saingra Y; Giorgi R; Bouvier C; Pellissier JF; Berland Y
    Am J Kidney Dis; 2000 Jan; 35(1):13-20. PubMed ID: 10620538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histological predictors of renal outcome in lupus nephritis: the importance of tubulointerstitial lesions and scoring of glomerular lesions.
    Obrișcă B; Jurubiță R; Andronesi A; Sorohan B; Achim C; Bobeica R; Gherghiceanu M; Mandache E; Ismail G
    Lupus; 2018 Aug; 27(9):1455-1463. PubMed ID: 29759047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The renal metallothionein expression profile is altered in human lupus nephritis.
    Faurschou M; Penkowa M; Andersen CB; Starklint H; Jacobsen S
    Arthritis Res Ther; 2008; 10(4):R76. PubMed ID: 18601746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of southern Sweden: the clinical utility of the ACR renal response criteria and predictors for renal outcome.
    Nived O; Hallengren CS; Alm P; Jönsen A; Sturfelt G; Bengtsson AA
    Scand J Rheumatol; 2013; 42(5):383-9. PubMed ID: 23829689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal expression of intercellular adhesion molecule-1 in immunoglobulin A nephropathy: tubulointerstitial injury and prognosis.
    Arrizabalaga P; Solé M; Abellana R; Ascaso C; Cardesa A
    Virchows Arch; 2001 Jul; 439(1):27-34. PubMed ID: 11499837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival.
    Sisó A; Ramos-Casals M; Bové A; Brito-Zerón P; Soria N; Muñoz S; Testi A; Plaza J; Sentís J; Coca A
    Lupus; 2008 Apr; 17(4):281-8. PubMed ID: 18413408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary clusterin-a novel urinary biomarker associated with pediatric lupus renal histopathologic features and renal survival.
    Wu CY; Yang HY; Chien HP; Tseng MH; Huang JL
    Pediatr Nephrol; 2018 Jul; 33(7):1189-1198. PubMed ID: 29511890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of renal outcomes in patients with crescentic lupus nephritis.
    Chen S; Tang Z; Zhang H; Hu W; Liu Z
    Am J Med Sci; 2015 Apr; 349(4):298-305. PubMed ID: 25607514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glomerular c4d staining can be an indicator of disease activity in lupus nephritis.
    Sahin OZ; Gurses S; Taslı F; Yavas H; Ersoy R; Uzum A; Cirit M
    Ren Fail; 2013; 35(2):222-5. PubMed ID: 23176021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptor 9 and vascular endothelial growth factor levels in human kidneys from lupus nephritis patients.
    Frieri M; Samih MA; Dzhindzhikhashvili M; Liu H; Balsam L; Rubinstein S
    J Nephrol; 2012; 25(6):1041-6. PubMed ID: 22344539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lupus nephritis: prognostic factors in children.
    McCurdy DK; Lehman TJ; Bernstein B; Hanson V; King KK; Nadorra R; Landing BH
    Pediatrics; 1992 Feb; 89(2):240-6. PubMed ID: 1734390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy.
    Hill GS; Delahousse M; Nochy D; Thervet E; Vrtovsnik F; Rémy P; Glotz D; Bariéty J
    Kidney Int; 2002 Jun; 61(6):2176-86. PubMed ID: 12028458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal cell apoptosis in human lupus nephritis: a histological study.
    Faurschou M; Penkowa M; Andersen CB; Starklint H; Jacobsen S
    Lupus; 2009 Oct; 18(11):994-9. PubMed ID: 19762401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new morphologic index for the evaluation of renal biopsies in lupus nephritis.
    Hill GS; Delahousse M; Nochy D; Tomkiewicz E; Rémy P; Mignon F; Méry JP
    Kidney Int; 2000 Sep; 58(3):1160-73. PubMed ID: 10972679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of cell adhesion molecules in tubulointerstitial nephritis associated with Sjögren's syndrome.
    Matsumura R; Umemiya K; Nakazawa T; Ochiai K; Kagami M; Tomioka H; Tanabe E; Sugiyama T; Sueishi M
    Clin Nephrol; 1998 Feb; 49(2):74-81. PubMed ID: 9524776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is the value of repeat kidney biopsies in patients with lupus nephritis?
    Morales E; Trujillo H; Bada T; Alonso M; Gutiérrez E; Rodríguez E; Gutiérrez E; Galindo M; Praga M
    Lupus; 2021 Jan; 30(1):25-34. PubMed ID: 33081588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of DNA topoisomerases in chronic proliferative kidney disease.
    Ivanova LV; Rudolph P; Kellner U; Jürgensen A; Tareeva IE; Alm P; Proppe D
    Kidney Int; 2000 Oct; 58(4):1603-12. PubMed ID: 11012894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of renal outcome in diffuse proliferative glomerulonephritis in systemic lupus erythematosus.
    Mosca M; Pasquariello A; Tavoni A; Moriconi L; Moneta I; Innocenti M; Bencivelli W; Bombardieri S
    Lupus; 1997; 6(4):371-8. PubMed ID: 9175022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.
    Gluhovschi C; Velciov S; Kaycsa A; Gluhovschi G; Petrica L; Marian R; Bozdog G; Gadalean F; Bob F; Cioca D; Vernic C
    Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):163-9. PubMed ID: 21651460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.